Synthesis and Pharmacological Characterization of 3-[2-((3aR,9bR)-cis-6-Methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e]isoindol-2-yl)ethyl]pyrido[3',4':4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione (A-131701): A Uroselective�1~A Adrenoceptor Antagonist for the Symptomatic Treatment of Benign Prostatic Hyperplasia